期刊文献+

CD4+CD25+Foxp3+T—reg细胞在大鼠肝移植天然免疫耐受模型中的作用 被引量:2

CD4+CD25 + Foxp3+ T-reg cells play an important role in na(i)ve immune tolerance in rat liver transplantation
原文传递
导出
摘要 目的 通过采用流式细胞技术对比分析研究,大鼠肝移植免疫耐受模型中CD4+CD25+Foxp3+T+reg细胞亚群的分布变化来研究揭示CD4+CD25+Foxp3+T-reg细胞亚群在移植免疫耐受过程中发挥的重要作用.方法 通过改良的Kamada"二袖套法"建立两种不同种属大鼠的免疫耐受和急性免疫排斥模型,再通过流式细胞技术检测两个模型大鼠CD4+CD25+Foxp3+T-reg细胞亚群分布有无区别.主要观察指标:两组肝移植大鼠的存活率比较,应用常规HE染色法观察移植肝组织病理学变化,检测CD4+CD25+Foxp3+T-reg细胞亚群在两组大鼠,肝脏、外周血、胸腺和脾脏总单核细胞数中所占的百分比.RT-PCR检测移植肝脏Foxp3 mRNA的表达水平.结果 耐受组大鼠可以不服用任何免疫抑制药物而长期存活(〉2个月),且排斥组大鼠最多只能存活7~10d,免疫耐受组在肝脏、外周血、脾脏和胸腺单核细胞中CD4+CD25+Foxp3+T-reg细胞亚群所占的比例明显高于排斥组(P〈0.05),且在移植肝脏中,免疫耐受组的Foxp3 mRNA表达含量明显高于排斥组.结论 在LEW→DA的大鼠免疫耐受模型中,CD4+CD25+Foxp3+T-reg细胞亚群细胞数量和比例明显升高,提示CD4+CD25+Foxp3+T-reg细胞亚群在移植免疫耐受过程中发挥着重要作用,从而为我们临床诱导免疫耐受提供一条新的思路.我们可以通过体外扩增抗原特异性的天然存在的调节性T细胞来抑制效应T细胞的激活和扩增,从而帮助诱导移植免疫耐受和抑制移植物排斥. Objective To study the effect of CD4+ CD25+ Foxp3 + T-reg cells in na(i)ve immune tolerance using a rat liver transplantation model, we monitored the changes of this population cell of CD4+ CD25+ Foxp3+ T-reg cells in liver、thymus、spleen and blood by flow cytometry technique. Methods Na(i)ve immune tolerance model of rat liver transplantation was established (LEW→DA) ,The rejection group (DA→LEW) was used as the control group. CD4+ CD25+ Foxp3+ T-reg cells were respectively extracted and measured in liver、thymus、 spleen and blood. Simultaneously, we recorded the survival rate of rats and liver graft pathological changes in every group. The expression level of Foxp3 mRNA in every group was monitored. Results DA rat in tolerance group could acquire long-time survival without any immunosuppressive drug. Compared with rejection group,CD4+ CD25+ Eoxp3+ T-reg cells in tolerance group were significantly increased, especially in blood. The expression level of Foxp3 mRNA is significantly higher(P〈0. 05). Conclusions In tolerance group (LEW→DA), the number and percentage of CD4 + CD25 + Foxp3 + T-reg cell were both significantly increased. It suggests that CD4 + CD25 + Foxp3 + T-reg cells play an important role in na(i)ve immune tolerance model of rat liver transplantation. This new sight could lead to induction immune tolerance and suppression graft rejection.
出处 《中华小儿外科杂志》 CSCD 北大核心 2010年第6期448-452,共5页 Chinese Journal of Pediatric Surgery
基金 基金项目:国家自然科学基金资助项目(30700773)
关键词 肝移植 免疫耐受 T淋巴细胞 调节性 Liver transplantation Immune tolerance T lymphocytes, regulatory
  • 相关文献

参考文献15

  • 1高晓明,鲁琰.CD4^+CD25^+调节性T细胞的研究现状及展望[J].细胞与分子免疫学杂志,2002,18(3):201-202. 被引量:13
  • 2肖江卫,夏树森,金先庆,王崇树,魏寿江,周彤,王城,李忆秋.转染血红素氧合酶-1基因减轻大鼠脂肪肝移植后的缺血再灌注损伤[J].中华器官移植杂志,2008,29(11):652-656. 被引量:3
  • 3Demetrius J,Batts KP,Dhillon AP,et al.Banff schema for grading liver allograft rejection:an international consensus document.Hepatology,1997,25(3):658-663.
  • 4肖江卫,金先庆,王崇树,王城,李忆秋.诱导血红素加氧酶-1高表达对大鼠减体积肝移植生存的影响[J].中华小儿外科杂志,2006,27(10):545-550. 被引量:3
  • 5Sakaguchi S,Sakaguchi N,Asano M,et al.Immunolo gic selftolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25).Break down of single mechanism of self-tolerance causes various autoimmune diseases.J Immunol,1995,155(3):1151-1164.
  • 6Nishimura E,Sakihama T,Setoguchi R,et al.Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3 + CD25 +CD4 + regulatory T cells.Int Immunol,2004,16 (8):1189-1201.
  • 7Demirkiran A,Kok A,Kwekkeboom J,et al.Low circulating regulatory T-cell levels after acute rejection in liver transplantation Liver Transplantation,2006,2 (2):277-284.
  • 8Hori S,Nomura T,Sakaguchi S.Control of regulatory T cell development by the transcription factor Foxp3.Science,2003,299 (5609):1057-1061.
  • 9Fontenot JD,Gavin MA,Rudensky AY.Foxp3 programs the development and function of CD4 + CD25 + regulatory T cells.Nature Immunol,2003,4(4):330-336.
  • 10Khattri R,Cox T,Yasayko SA,et al.An essential role for Scurfin in CD4 + CD25 + Tregulatory cells.Nature Immunol,2003,4 (4):337-342.

二级参考文献35

  • 1肖江卫,金先庆,王崇树,王城,李忆秋.诱导血红素加氧酶-1高表达对大鼠减体积肝移植生存的影响[J].中华小儿外科杂志,2006,27(10):545-550. 被引量:3
  • 2Loinaz C, Gonzalez EM. Marginal donors in liver transplanta tion. Hepatogastroenterology, 2000, 47 (31) : 256-263.
  • 3Teramoto K, Bowers JL, Khettry U, et al. A rat fatty liver transplant model. Transplantation, 1993, 55(4) :737-741.
  • 4Fiorini RN, Kirtz J, Periyasamy B, et al. Development of an unbiased method for the estimation of liver steatosis. Clin Transplant, 2004, 18(6) :700-706.
  • 5Yang ZF, Tsui TY, Ho DW, et al. Heme oxygenase-1 poten tiates the survival of small-for-size liver graft. Liver Transpl, 2004, 10(6) :784-793.
  • 6Suzuki S, Toledo-Pereyra LH, Rodriguez FJ, et al. Neutrophil infiltration as an important factor in liver isehemia and reperfusion injury. Modulating effects of FK506 and cyclospo rine. Transplantation, 1993, 55(6) :1265-1272.
  • 7Kato H, Amersi F, Buelow R, et al. Heme oxygenase-1 overexpression protects rat livers from isehemia/reperfusion injury with extended eold preservation. Am J Transplant, 2001, 1 (2) : 121-128.
  • 8Marsman WA, Wiesner RH, Rodriguez L, et al. Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation, 1996, 62 ( 9 ) : 1246-1251.
  • 9Nadig SN, Bratton CF, Karp SJ. Marginal donors in liver transplantation: expanding the donor pool. J Surg FAuc, 2007, 64 ( 1 ) : 46-50.
  • 10Choi AM, Alam J. Heme oxygenase-1 : function, regulation, and implication of a novel stress-inducible protein in oxidantinduced lung injury. Am J Respir Cell Mol Biol, 1996, 15 ( 1 ) : 9-19.

共引文献16

同被引文献18

  • 1Lechler RI, Sykes M, Thomson AW, et al. Organ transplantation-how much of the promise has been malized?[J]. Nature Medicine, 2005, 11(6): 605-613.
  • 2Saidi RF, Hejazii Kenari SK. Clinical transplantation and tolerance: are we there yet?[J]. Int J Organ Transplant Med, 2014, 5(4): 137-145.
  • 3Sakaguchi S, Yamaguchi T, Nomura T, et al. Regulatory T ceils and immune tolerance[J]. Cell, 2008, 133(5): 775-787.
  • 4Roncarolo MG, Battaglia M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans[J]. Nat Rev Immunol, 2007, 7(8): 585-598.
  • 5Banff schema for grading liver allografl rejection: an international consensus document[J]. Hcpatology, 1997, 25: 658-663.
  • 6Campbell DJ, Koch MA. Phenotypical and flmctional specialization of FOXP3+ regulatory T cells[J]. Nat Rev Immunol, 2011, 11(2): 119-130.
  • 7Feuerer M, Hill JA, Mathis D, et al. Foxp3+ regulatory T cells: differentiation, specification, subphenotypes[J]. Nat Immunol, 2009, 10(7): 689-695.
  • 8Tang Q, Bluestone JA, Kang SM. CD4Toxp3+ regulatory T cell therapy in transplantation[J]. J Mol Cell Biol, 2012, 4(1): 11-21.
  • 9Levine AG, Arvey A, Jin W, et al. Continuous requirement for the TCR in regulatory T cell function[J]. Nat Immunol, 2014, 15(11): 1070-1078.
  • 10Williams LM, Rudensky AY. Maintenance of the Foxp3-dependent developmental prosram in mature regulatory T cells re, quires continued expression of Foxp3[J]. Nature Immtmol, 2007, 8(3): 277-284.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部